New medication has emerged to fight obesity, and the evidence suggests it is by far the best yet. Those who took it in clinical trials lost a significant 22.5% of their body weight on average, 50% more than the nearest rival. These game-changing results have attracted so much interest that analysts think US pharmaceutical giant may be sitting on what could be the
